Metformin and cancer mortality
The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...
Saved in:
Main Author: | Lev Mikhaylovich Bershteyn |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/05da729af1a04fbb8decb7c01a66bd6a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
by: Lev Mikhaylovich Bershteyn, et al.
Published: (2014) -
Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017) -
Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
by: Anna I. Sazonova, et al.
Published: (2016) -
Diabetes, obesity and cancer: risk and anti-risk factors
by: Lev Mikhaylovich Bershteyn
Published: (2012) -
Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015)